Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

BDMD vs ISRG

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
BDMD
Baird Medical Investment Holdings Limited

Medical - Devices

HealthcareNASDAQ • CN
Market Cap$65M
5Y Perf.-81.9%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$160.44B
5Y Perf.+25.7%

BDMD vs ISRG — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
BDMD logoBDMD
ISRG logoISRG
IndustryMedical - DevicesMedical - Instruments & Supplies
Market Cap$65M$160.44B
Revenue (TTM)$37M$10.58B
Net Income (TTM)$12M$2.98B
Gross Margin88.2%66.3%
Operating Margin41.4%30.5%
Forward P/E3.6x43.7x
Total Debt$21M$303M
Cash & Equiv.$3M$3.37B

BDMD vs ISRGLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

BDMD
ISRG
StockDec 21May 26Return
Baird Medical Inves… (BDMD)10018.1-81.9%
Intuitive Surgical,… (ISRG)100125.7+25.7%

Price return only. Dividends and distributions are not included.

Quick Verdict: BDMD vs ISRG

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: BDMD and ISRG are tied at the top with 3 categories each — the right choice depends on your priorities. Intuitive Surgical, Inc. is the stronger pick specifically for growth and revenue expansion and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
BDMD
Baird Medical Investment Holdings Limited
The Value Play

BDMD has the current edge in this matchup, primarily because of its strength in value and quality.

  • Lower P/E (3.6x vs 43.7x)
  • 33.6% margin vs ISRG's 28.2%
  • 18.5% ROA vs ISRG's 14.8%, ROIC 22.6% vs 15.0%
Best for: value and quality
ISRG
Intuitive Surgical, Inc.
The Income Pick

ISRG is the clearest fit if your priority is income & stability and growth exposure.

  • beta 1.02
  • Rev growth 20.5%, EPS growth 22.6%, 3Y rev CAGR 17.4%
  • 5.6% 10Y total return vs BDMD's -81.6%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthISRG logoISRG20.5% revenue growth vs BDMD's 17.7%
ValueBDMD logoBDMDLower P/E (3.6x vs 43.7x)
Quality / MarginsBDMD logoBDMD33.6% margin vs ISRG's 28.2%
Stability / SafetyISRG logoISRGBeta 1.02 vs BDMD's 1.15, lower leverage
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)ISRG logoISRG-14.8% vs BDMD's -66.7%
Efficiency (ROA)BDMD logoBDMD18.5% ROA vs ISRG's 14.8%, ROIC 22.6% vs 15.0%

BDMD vs ISRG — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

BDMDBaird Medical Investment Holdings Limited

Segment breakdown not available.

ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B

BDMD vs ISRG — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLBDMDLAGGINGISRG

Income & Cash Flow (Last 12 Months)

BDMD leads this category, winning 3 of 4 comparable metrics.

ISRG is the larger business by revenue, generating $10.6B annually — 285.7x BDMD's $37M. BDMD is the more profitable business, keeping 33.6% of every revenue dollar as net income compared to ISRG's 28.2%.

MetricBDMD logoBDMDBaird Medical Inv…ISRG logoISRGIntuitive Surgica…
RevenueTrailing 12 months$37M$10.6B
EBITDAEarnings before interest/tax$3.8B
Net IncomeAfter-tax profit$3.0B
Free Cash FlowCash after capex$2.8B
Gross MarginGross profit ÷ Revenue+88.2%+66.3%
Operating MarginEBIT ÷ Revenue+41.4%+30.5%
Net MarginNet income ÷ Revenue+33.6%+28.2%
FCF MarginFCF ÷ Revenue-24.8%+26.8%
Rev. Growth (YoY)Latest quarter vs prior year+23.0%
EPS Growth (YoY)Latest quarter vs prior year+18.8%
BDMD leads this category, winning 3 of 4 comparable metrics.

Valuation Metrics

BDMD leads this category, winning 4 of 4 comparable metrics.

At 3.6x trailing earnings, BDMD trades at a 94% valuation discount to ISRG's 57.4x P/E. On an enterprise value basis, BDMD's 5.0x EV/EBITDA is more attractive than ISRG's 43.4x.

MetricBDMD logoBDMDBaird Medical Inv…ISRG logoISRGIntuitive Surgica…
Market CapShares × price$65M$160.4B
Enterprise ValueMkt cap + debt − cash$83M$157.4B
Trailing P/EPrice ÷ TTM EPS3.63x57.40x
Forward P/EPrice ÷ next-FY EPS est.43.67x
PEG RatioP/E ÷ EPS growth rate2.64x
EV / EBITDAEnterprise value multiple4.95x43.44x
Price / SalesMarket cap ÷ Revenue1.76x15.94x
Price / BookPrice ÷ Book value/share1.15x9.13x
Price / FCFMarket cap ÷ FCF64.42x
BDMD leads this category, winning 4 of 4 comparable metrics.

Profitability & Efficiency

BDMD leads this category, winning 5 of 8 comparable metrics.

BDMD delivers a 33.0% return on equity — every $100 of shareholder capital generates $33 in annual profit, vs $17 for ISRG. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to BDMD's 0.53x. On the Piotroski fundamental quality scale (0–9), ISRG scores 6/9 vs BDMD's 2/9, reflecting solid financial health.

MetricBDMD logoBDMDBaird Medical Inv…ISRG logoISRGIntuitive Surgica…
ROE (TTM)Return on equity+33.0%+16.9%
ROA (TTM)Return on assets+18.5%+14.8%
ROICReturn on invested capital+22.6%+15.0%
ROCEReturn on capital employed+37.8%+16.5%
Piotroski ScoreFundamental quality 0–926
Debt / EquityFinancial leverage0.53x0.02x
Net DebtTotal debt minus cash$18M-$3.1B
Cash & Equiv.Liquid assets$3M$3.4B
Total DebtShort + long-term debt$21M$303M
Interest CoverageEBIT ÷ Interest expense26.55x
BDMD leads this category, winning 5 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

ISRG leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in ISRG five years ago would be worth $16,086 today (with dividends reinvested), compared to $1,841 for BDMD. Over the past 12 months, ISRG leads with a -14.8% total return vs BDMD's -66.7%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.2% vs BDMD's -44.2% — a key indicator of consistent wealth creation.

MetricBDMD logoBDMDBaird Medical Inv…ISRG logoISRGIntuitive Surgica…
YTD ReturnYear-to-date+32.8%-19.6%
1-Year ReturnPast 12 months-66.7%-14.8%
3-Year ReturnCumulative with dividends-82.7%+49.0%
5-Year ReturnCumulative with dividends-81.6%+60.9%
10-Year ReturnCumulative with dividends-81.6%+556.9%
CAGR (3Y)Annualised 3-year return-44.2%+14.2%
ISRG leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

ISRG leads this category, winning 2 of 2 comparable metrics.

ISRG is the less volatile stock with a 1.02 beta — it tends to amplify market swings less than BDMD's 1.15 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ISRG currently trades 74.8% from its 52-week high vs BDMD's 24.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricBDMD logoBDMDBaird Medical Inv…ISRG logoISRGIntuitive Surgica…
Beta (5Y)Sensitivity to S&P 5001.15x1.02x
52-Week HighHighest price in past year$7.26$603.88
52-Week LowLowest price in past year$0.76$427.84
% of 52W HighCurrent price vs 52-week peak+24.5%+74.8%
RSI (14)Momentum oscillator 0–10049.642.2
Avg Volume (50D)Average daily shares traded1.0M1.8M
ISRG leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.
MetricBDMD logoBDMDBaird Medical Inv…ISRG logoISRGIntuitive Surgica…
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$622.60
# AnalystsCovering analysts55
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises1
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.4%
Insufficient data to determine a leader in this category.
Key Takeaway

BDMD leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). ISRG leads in 2 (Total Returns, Risk & Volatility).

Best OverallBaird Medical Investment Ho… (BDMD)Leads 3 of 6 categories
Loading custom metrics...

BDMD vs ISRG: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is BDMD or ISRG a better buy right now?

For growth investors, Intuitive Surgical, Inc.

(ISRG) is the stronger pick with 20. 5% revenue growth year-over-year, versus 17. 7% for Baird Medical Investment Holdings Limited (BDMD). Baird Medical Investment Holdings Limited (BDMD) offers the better valuation at 3. 6x trailing P/E, making it the more compelling value choice. Analysts rate Intuitive Surgical, Inc. (ISRG) a "Buy" — based on 55 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — BDMD or ISRG?

On trailing P/E, Baird Medical Investment Holdings Limited (BDMD) is the cheapest at 3.

6x versus Intuitive Surgical, Inc. at 57. 4x.

03

Which is the better long-term investment — BDMD or ISRG?

Over the past 5 years, Intuitive Surgical, Inc.

(ISRG) delivered a total return of +60. 9%, compared to -81. 6% for Baird Medical Investment Holdings Limited (BDMD). Over 10 years, the gap is even starker: ISRG returned +556. 9% versus BDMD's -81. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — BDMD or ISRG?

By beta (market sensitivity over 5 years), Intuitive Surgical, Inc.

(ISRG) is the lower-risk stock at 1. 02β versus Baird Medical Investment Holdings Limited's 1. 15β — meaning BDMD is approximately 12% more volatile than ISRG relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 53% for Baird Medical Investment Holdings Limited — giving it more financial flexibility in a downturn.

05

Which is growing faster — BDMD or ISRG?

By revenue growth (latest reported year), Intuitive Surgical, Inc.

(ISRG) is pulling ahead at 20. 5% versus 17. 7% for Baird Medical Investment Holdings Limited (BDMD). On earnings-per-share growth, the picture is similar: Intuitive Surgical, Inc. grew EPS 22. 6% year-over-year, compared to 19. 5% for Baird Medical Investment Holdings Limited. Over a 3-year CAGR, ISRG leads at 17. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — BDMD or ISRG?

Baird Medical Investment Holdings Limited (BDMD) is the more profitable company, earning 33.

6% net margin versus 28. 4% for Intuitive Surgical, Inc. — meaning it keeps 33. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BDMD leads at 41. 4% versus 29. 3% for ISRG. At the gross margin level — before operating expenses — BDMD leads at 88. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Which pays a better dividend — BDMD or ISRG?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

08

Is BDMD or ISRG better for a retirement portfolio?

For long-horizon retirement investors, Intuitive Surgical, Inc.

(ISRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 02), +556. 9% 10Y return). Both have compounded well over 10 years (ISRG: +556. 9%, BDMD: -81. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between BDMD and ISRG?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

BDMD

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 8%
  • Net Margin > 20%
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform BDMD and ISRG on the metrics below

Revenue Growth>
%
(BDMD: 17.7% · ISRG: 23.0%)
Net Margin>
%
(BDMD: 33.6% · ISRG: 28.2%)
P/E Ratio<
x
(BDMD: 3.6x · ISRG: 57.4x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.